WINNIPEG, Dec. 5, 2011 /PRNewswire/ - IMRIS Inc. (NASDAQ: IMRS; TSX: IM)
("IMRIS" or the "Company") today announced that Kelly McNeill, IMRIS
Chief Financial Officer will present at the Canaccord Genuity
Cardiovascular, Aesthetics & Metabolic Disorders Conference on December
6, 2011 at 3:00 pm Pacific Time. An audio webcast of Mr. McNeill's
presentation will be available at www.imris.com.
About IMRIS
IMRIS (NASDAQ: IMRS; TSX: IM) is a global leader in providing image
guided therapy solutions through its VISIUS Surgical Theatre - a
revolutionary, multifunctional surgical environment that provides
unmatched intraoperative vision to clinicians to assist in decision
making and enhance precision in treatment. VISIUS Surgical Theatres
serve the neurosurgical, cardiovascular and cerebrovascular markets and
have been selected by leading medical institutions around the world.
SOURCE IMRIS Inc.